O'Driscoll Kathryn 4
4 · Zymeworks Inc. · Filed Nov 19, 2020
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
O'Driscoll Kathryn
Chief People Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-11-18−2,920→ 97,080 totalExercise: $34.24Exp: 2029-11-07→ Common Shares (2,920 underlying) - Exercise/Conversion
Common Shares
2020-11-18$34.24/sh+2,920$99,981→ 2,920 total
Footnotes (1)
- [F1]Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of November 8, 2019, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.